Frontier Biotech established its headquarter, R&D center and manufacturing facility in Nanjing, China. The existing solid-phase peptide synthesis and freeze-dry injectable product lines are GMP-certified by the National Medical Products Administration (NMPA) as part of the Aikening ®'s approval process. In addition to building a strong core team for R&D, development, manufacturing and commercial operation, Frontier Biotech has been successfully leveraging strategic partnerships, collaboration and licensing relationships to shorten the development cycle and mitigate the development risk. This allows Frontier Biotech to collaborate with manufacturers and commercial distributors to bring innovative medicines to patients as quickly and safely as possible.